An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

Amar Gupta, Ray Woosley, Igor Crk, Surendra Sarnikar
Copyright: © 2007 |Pages: 16
DOI: 10.4018/jhisi.2007070106
OnDemand:
(Individual Articles)
Available
$37.50
Current Special Offers
No Current Special Offers
TOTAL SAVINGS: $37.50

Abstract

Adverse drug events impose a large cost on the society in terms of lives and health care costs. In this article, we propose an information technology architecture for enabling the monitoring of adverse drug events in an outpatient setting as a part of the post marketing surveillance program. The proposed system architecture enables the development of a Web-based drug effectiveness reporting and monitoring system that builds on previous studies demonstrating the feasibility of a system in which community pharmacists identify and report adverse drug events. We define the key technical requirements of such a monitoring and reporting system, identify the critical factors that influence the successful implementation and use of the system, and propose information technology solutions that satisfy these requirements.

Complete Article List

Search this Journal:
Reset
Volume 19: 1 Issue (2024)
Volume 18: 1 Issue (2023)
Volume 17: 2 Issues (2022)
Volume 16: 4 Issues (2021)
Volume 15: 4 Issues (2020)
Volume 14: 4 Issues (2019)
Volume 13: 4 Issues (2018)
Volume 12: 4 Issues (2017)
Volume 11: 4 Issues (2016)
Volume 10: 4 Issues (2015)
Volume 9: 4 Issues (2014)
Volume 8: 4 Issues (2013)
Volume 7: 4 Issues (2012)
Volume 6: 4 Issues (2011)
Volume 5: 4 Issues (2010)
Volume 4: 4 Issues (2009)
Volume 3: 4 Issues (2008)
Volume 2: 4 Issues (2007)
Volume 1: 4 Issues (2006)
View Complete Journal Contents Listing